TD Asset Management
MBX

TD Asset Management’s MBX Biosciences MBX Stock Holding History

TD Asset Management’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.28M Sell
95,598
-20,400
-18% -$712K ﹤0.01% 800
2026
Q1 		$3.46M Buy
115,998
+14,548
+14% +$495K ﹤0.01% 860
2025
Q4 		$3.2M Sell
101,450
-17,342
-15% -$421K ﹤0.01% 884
2025
Q3 		$2.08M Sell
118,792
-52,512
-31% -$702K ﹤0.01% 961
2025
Q2 		$1.95M Buy
171,304
+19,800
+13% +$202K ﹤0.01% 947
2025
Q1 		$1.12M Buy
151,504
+114,904
+314% +$1.21M ﹤0.01% 1055
2024
Q4 		$675K Sell
36,600
-8,182
-18% -$174K ﹤0.01% 1150
2024
Q3 		$1.07M Buy
+44,782
New +$1.02M ﹤0.01% 1170

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

TD Asset Management's MBX Position: Q2 2026 in Review

TD Asset Management reduced its MBX Biosciences (MBX) stake by 18% in Q2 2026, selling an estimated $712K and leaving 95,598 shares worth $5.28M. The position accounts for ﹤0.01% of the portfolio, ranked #800.

TD Asset Management first reported a position in MBX in Q3 2024 and has held it in 8 quarters since. 172 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • TD Asset Management held 95,598 shares of MBX Biosciences worth $5.28M as of Q2 2026.
  • TD Asset Management sold 20,400 MBX Biosciences shares in Q2 2026, an estimated $712K.
  • MBX Biosciences made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #800 holding.
  • TD Asset Management first reported a position in MBX Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 172 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.